Bone Biologics Corp. (BBLG) vs Finch Therapeutics Group, Inc. (FNCHQ)

Bone Biologics Corp. and Finch Therapeutics Group, Inc. are both Biotechnology companies. Finch Therapeutics Group, Inc. is the larger, with a market value of $1.6M against $1.4M — 1.2× the size. Across the 8 metrics below, Bone Biologics Corp. leads on 4 and Finch Therapeutics Group, Inc. on 4.

Valuation

Metric BBLG FNCHQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m 27.07 11.47
P/B 0.22 1.17 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 47.86 10.73
Earnings yield (285.42%) (85.22%) (28.84%)
Free cash flow yield (304.81%) (100.64%) (23.03%)

Profitability

Metric BBLG FNCHQ Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (54.96%) (67.28%) (57.72%)
Return on assets (50.55%) (25.20%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG FNCHQ Biotechnology median
Revenue growth (TTM) — (96.00%) 5.64%
EPS growth (last fiscal year) 90.85% 35.36% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BBLG FNCHQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 3.87 4.73
Net debt to EBITDA 1.65 0.31 0.96

Dividend

Metric BBLG FNCHQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BBLG FNCHQ Biotechnology median
Market cap 1.35m 1.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack